nephroprotective

(redirected from nephroprotection)

nephroprotective

(nef″rō-prŏ-tek′tiv) [ nephro- + protective]
Tending to preserve kidney function, esp. when the kidneys are exposed to unusual or unique stresses.
nephroprotection (′shŏn)
References in periodicals archive ?
(23) Nephroprotection is attributed to both antioxidant status and mitochondrial support.
All above mentioned research work agrees with our findings of significantly greater nephroprotection shown by group D.
STS (also named sodium hyposulfte, chemically Na2O3S2 or Na2S2O3) is the most common drug being used of-label to treat calciphylaxis, primarily used for the treatment of cyanide poisoning and urolithiasis, and as nephroprotection during cisplatin administration.
Cisplatin-induced nephrotoxicity and targets of nephroprotection: An update.
Seven-year outcomes from the BENEFIT study (Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial) showed that, among renal transplant patients who received regimens incorporating belatacept, the mean estimated glomerular filtration rate (eGFR) increased over 84 months as compared to the cyclosporine group, in whom the eGFR declined [5].
Additionally, there is an ongoing clinical trial testing the nephroprotection effects of this double inhibition [35,39].
dos Santos, "Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update," Archives of Toxicology, vol.
Koneru et al., "Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection," Toxicology and Applied Pharmacology, vol.
showed that diosmin offered nephroprotection in TCE-intoxicated mice by reducing the expression of Bax, p53, caspase-3, caspase-7, and caspase-9 [47].
The majority of our patients were treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers as part of nephroprotection in DKD [34].